3Pemg RP,Chen YM,Ming J,et al. Gemcitabine versus the combination of cisplatin and etoposide in patiens with inoperable nonsmall cell lung cancer in a phase randomized study[J].J Clin Oncol,1997,15(5):2097-2101. 被引量：1
1[3]Castellano D,Lianes P,Paz-Ares L,et al. A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for non-small-cell lung cancer[J].Ann Oncol,1998,9(4):457-459. 被引量：1
2[4]Manegold C,Zatloukal P,Krejcy K,et al.Gemcitabine in non-small-cell-lung-cancer[J].Invest New Drugs,2000,18(1):29-42. 被引量：1
3Frances A. Chemotherapy for non small cell lung cancer:have we reached a new plateau[J].Semin Oncol,1999,26(1):3-11. 被引量：1
4Pemg R P,Chen Y M,Ming J,et al. Gemcitabine versus the combination of cisplatin and etoposide in patiens with inoperable non small cell lung cancer in a phase randomized study[J].J Clin Oncol,1997,15(5):2097-2101. 被引量：1
5Rafeal R,Tonato M,Sandler A,et al. The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non small cell lung cancer[J].Semin Oncol,1998,25(4):27-34. 被引量：1
6Dembernowsky P,Giaccone G,Sandler A,et al. Gemcitabine and peceltaxol combination in non small cell lung cancer[J].Semin Oncol,1998,25(4):44-50. 被引量：1
7Crino L,Scagliotti G,Marangolo M,et al. Cisplatin-gemcitabine combination in advanced non small cell lung cancer:a phase study[J].J Clin Oncol,1997,15(1):297-303. 被引量：1
